终末期肝病模型（MELD）评分对重新列入名单的候选人有效吗？

Does MELD work for relisted candidates?

Edwards Erick, Harper Ann

United Network for Organ Sharing, Richmond, VA, USA.

Liver Transpl. 2004 Oct;10(10 Suppl 2):S10-6. doi: 10.1002/lt.20271.

Abstract

Based on OPTN data, the ability of the model for end-stage liver disease (MELD) to predict short-term pretransplant and posttransplant outcomes was assessed. 2. Concordance with pretransplant mortality was excellent. 3. Concordance with pretransplant mortality was better for candidates listed for a primary transplant. 4. Of the MELD components, there were no statistically significant differences in the effects on pretransplant mortality between candidates listed for a primary or a repeat transplant. 5. Concordance with posttranplant outcomes was poor.

摘要

根据器官共享联合网络（OPTN）的数据，评估了终末期肝病模型（MELD）预测移植前和移植后短期结局的能力。2. 与移植前死亡率的一致性极佳。3. 对于初次移植登记的候选人，与移植前死亡率的一致性更好。4. 在MELD的组成部分中，初次移植或再次移植登记的候选人对移植前死亡率的影响没有统计学上的显著差异。5. 与移植后结局的一致性较差。